Tech Center 1600 • Art Units: 1675
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17861180 | MODIFIED IL-2 POLYPEPTIDES FOR TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES | Non-Final OA | Bright Peak Therapeutics AG |
| 17614272 | PEPTIDES | Non-Final OA | Hubro Therapeutics AS |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy